• CENTRE FOR COMMERCIALIZATION OF CANCER IMMUNOTHERAPY C3I



C3i is attending the 59th ASH Annual Meeting and Exposition!

C3i will attend the 59th ASH Annual Meeting and Exposition in Atlanta from December 9th to 12th to engage with researchers, clinicians and industry leaders in the Hematology field. François Bettez, our CEO as well as Dr Lambert Busque our CMO, and Dr Denis-Claude Roy ou CSO, will be representing and promoting C3i for its outstanding capacity to help biotech companies and pharmas to achieve their objectives. 

Get in touch to know more about C3i.

 

Contact: François Bettez

francois.bettez.cemtl@ssss.gouv.qc.ca